XML 45 R21.htm IDEA: XBRL DOCUMENT v3.19.3
Note 15 - Segment Information
9 Months Ended
Sep. 30, 2019
Notes to Financial Statements  
Segment Reporting Disclosure [Text Block]
15.
SEGMENT INFORMATION
 
The Company has determined that its continuing operations are
one
discrete segment consisting of biometric products. Geographically, North American sales accounted for approximately
79%
and
59%
of the Company’s total sales for the
three
months ended
September 30, 2019
and
2018,
respectively, and were approximately
56%
and
56%
of the Company’s total sales for the
nine
months ended
September 30, 2019
and
2018,
respectively.